During the last session, Spyre Therapeutics Inc (NASDAQ:SYRE)’s traded shares were 0.42 million, with the beta value of the company hitting 2.85. At the end
Spyre Therapeutics Inc (NASDAQ:SYRE)’s traded shares stood at 0.44 million during the last session, with the company’s beta value hitting 2.85. At the close of
During the last session, Spyre Therapeutics Inc (NASDAQ:SYRE)’s traded shares were 0.79 million, with the beta value of the company hitting 2.85. At the end
In the last trading session, 3.12 million shares of the Spyre Therapeutics Inc (NASDAQ:SYRE) were traded, and its beta was 2.88. Most recently the company’s
In today’s recent session, 1.34 million shares of the Spyre Therapeutics Inc (NASDAQ:SYRE) have been traded, and its beta is 2.88. Most recently the company’s
In the last trading session, 1.22 million Spyre Therapeutics Inc (NASDAQ:SYRE) shares changed hands as the company’s beta touched 2.92. With the company’s per share
In the latest trading session, 0.41 million Spyre Therapeutics Inc (NASDAQ:SYRE) shares changed hands as the company’s beta touched 2.92. With the company’s most recent
In last trading session, Spyre Therapeutics Inc (NASDAQ:SYRE) saw 0.43 million shares changing hands with its beta currently measuring 2.91. Company’s recent per share price
During the last session, Spyre Therapeutics Inc (NASDAQ:SYRE)’s traded shares were 0.39 million, with the beta value of the company hitting 2.91. At the end
Marketing Sentinel delivers exclusive content, news, articles, and comprehensive coverage of events in the USA and worldwide with a commitment to reliability, objectivity, and timeliness.
© 2024, Powered by Smart TechOne
